Showing 1 - 2 results of 2 for search 'Veronique Vanquickelberghe', query time: 0.02s Refine Results
  1. 1
    Comparative efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) without and with daratumumab (D‐VTd) in CASSIOPEIA versus VTd in PETHEMA/GEM in transplant‐eligible patients with newly diagnosed multiple myeloma, using propensity score matching

    Comparative efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) without and with daratumumab (D‐VTd) in CASSIOPEIA versus VTd in PETHEMA/GEM in transplant‐eligi... by Philippe Moreau, Cyrille Hulin, Sonja Zweegman, Mahmoud Hashim, Yannan Hu, Bart Heeg, Carla deBoer, Veronique Vanquickelberghe, Tobias Kampfenkel, Jianming He, Annette Lam, Sarah Cote, Pieter Sonneveld

    Published 2021-02-01
    Get full text
    Article
  2. 2
    Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib/thalidomide/dexamethasone in the phase 3 CASSIOPEIA study

    Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib/thalidomide/dexamethasone in the phase 3 CAS... by Cyrille Hulin, Fritz Offner, Philippe Moreau, Murielle Roussel, Karim Belhadj, Lotfi Benboubker, Denis Caillot, Thierry Facon, Laurent Garderet, Frédérique Kuhnowski, Anne-Marie Stoppa, Brigitte Kolb, Mourad Tiab, Kon-Siong Jie, Matthijs Westerman, Jérôme Lambert, Lixia Pei, Veronique Vanquickelberghe, Carla de Boer, Jessica Vermeulen, Tobias Kampfenkel, Pieter Sonneveld, Niels W.C.J. van de Donk

    Published 2021-03-01
    Get full text
    Article

Search Tools: